Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 69INDUSTRY 25NIH 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Aminolevulinic Acid × Clear all
NCT01898416 2013-10-31

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Tel-Aviv Sourasky Medical Center

Phase 2 Recruiting
140 enrolled
Sarcoma

The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an

Data powered by HemOnc (CC BY 4.0) Colophon âš¡